Tracking SARS-CoV-2 variants with ACROBiosystems
‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 
View as a Web Page
 
Facebook Twitter Vimeo
News Medical
COVID-19 Newsletter
The latest COVID-19 news from News Medical

Tracking SARS-CoV-2 variants

From D614G to Omicron, ACROBiosystems are continually making efforts

On Nov 26th, 2021, WHO designated the variant B.1.1.529 the fifth variant of concern, named Omicron. Until Dec 9th, nearly 1000 Omicron cases reported by 57 countries around the world. To support the research of Omicron, ACROBiosystems immediately organized an emergency response team and successfully developed a series of core research tools with high quality, including antigens, antibodies, pseudovirus and ELISA kits.

ACROBiosystems is dedicated to aiding the global COVID-19 response and will keep watching the emerging SARS-CoV-2 variants.

Read more
The most viewed COVID-19 news stories of 2021 were...

Scientists suspect Lambda SARS-CoV-2 variant most dangerous

A new study published on the bioRxiv* preprint server used molecular phylogenetic analysis to study the evolutionary trait of the Lambda variant.

Learn More
 

Pfizer-BioNTech and Moderna COVID-19 vaccines establish recall responses to reinfection

A study shows that certain COVID-19 vaccines generate a coordinated adaptive immune response that is capable of eliciting recall responses to future infection.

Discover More
Fighting against SARS-CoV-2 infection

300+ research tools to speed up COVID-19 vaccine R&D

Vaccination is the cornerstone to prevent and control the spread of infectious diseases. As a life science company, ACROBiosystems provide reagents for the global vaccine industry with the accumulated mature technology and experiences. 300+ products and customized services, including antigens, antibodies, pseudovirus and ELISA kits, covering all the dominant strains of SARS-CoV-2, are supplied to support vaccine development of all technological platforms.

Browse core research tools
The most viewed COVID-19 articles of 2021 were...

COVID-19 and the Gastrointestinal Tract

In this article, the impact of COVID-19 on the gastrointestinal tract is explored.

Learn More
 

COVID-19 and Autoimmune Diseases

COVID-19 has caused severe or critical illness in a significant minority of patients.

Learn More
Thinking about SARS-CoV-2 pandemic

Where do we go from here: A reflection of COVID-19

In Jan 2020, SARS-CoV-2 launched a global pandemic that remains circulated today. In less than two years, unimaginable achievement has been achieved about scientific research and vaccine development. However, there are still many black boxes about the virus. The continuous emergence of SARS-CoV-2 variants is a wake-up call. A reflection of COVID-19, including the achievement and unknown so far, was shared in the FREE eBook, following some possible solutions to related research, vaccine and diagnostics development.

Download the free eBook
More COVID-19 stories from 2021...

History of COVID-19

In this article, we take a look at the history of COVID-19 from the first recorded case to the current efforts to curb the spread of the disease with vaccination programs.

Read More
 

Blood Clotting and COVID-19 Vaccines

The risk of blood clotting is an extremely rare but serious side effect of vaccination against coronavirus disease 2019 (COVID-19).

Discover More
AZoNetwork UK Ltd.
NEO, 9 Charlotte St, Manchester, M1 4ET, UK
44 (0)161 457 7150

Why did you receive this email?
You recently requested related information from us and asked to be notified of additional information.

Not Interested Anymore?
Unsubscribe or Update your Notification Preferences

Copyright © 2000-2022